Please bookmark this page to stay up to date with all confirmed speakers.
Please bookmark this page to stay up to date with all confirmed speakers.
|Sir George Pickering Lecturer - Professor Sir Rory Collins, University of Oxford, UK
Rory Collins studied Medicine at St Thomas’s Hospital Medical School, London, and Statistics at George Washington University and Oxford University.
He came to Oxford in 1981 to run the ISIS “mega-trials” which showed that emergency treatment of heart attacks with streptokinase and aspirin halves mortality. Subsequently, his focus has involved showing that lowering LDL-cholesterol safely reduces the risk of having heart attacks and strokes.
Rory became Principal Investigator of the UK Biobank prospective study of 500,000 people in 2005. He was elected to the Fellowship of the UK Academy of Medical Science in 2004 and the Royal Society in 2015, and knighted by the Queen for services to Science in 2011.
|Mr Ali Albasri, University of Oxford, UK
Ali is a clinical pharmacist and researcher at the University of Oxford. His work focusses on the role of pharmacists in the management of hypertension. His research has led to the production of a ‘toolkit’ for pharmacists, aiding their delivery of hypertension management services. In 2017 he was awarded the Allied Health Professional award by the BIHS.
|Professor Clive Ballard, University of Exeter Medical School, UK
Clive Ballard is part of a growing team of outstanding dementia researchers at the University of Exeter Medical School. A world-renowned researcher, his research specialisms are drug-discovery, dementia prevention, treatment and care. He is an expert in Lewy Body Dementia and Parkinson’s Disease Dementia, and an advocate of better prescribing and treatment pathways to improve outcomes.
|Dr Guy Bewick, University of Aberdeen, UK
My group studies how nerve terminal sensitivity and function is modulated in model systems, using and developing a variety of techniques to do so. We discovered that stretch-sensitive nerve terminals, including baroreceptors, have a powerful self-regulating secretory system. Recent work indicates its unique pharmacology offers a promising novel drug target for treating hypertension.
|Dr Jeff Breckon, Sheffield Hallam University, UK
Dr Jeff Breckon is Head of the AWRC Behaviour Change Research Group at Sheffield Hallam University. He is a BPS and HCPC Chartered Psychologist and a member of MINT (Motivational Interviewing Network of Trainers) and BPS (British Psychological Association).
|Professor Morris Brown, Queen Mary University of London, UK
Morris Brown, FMedSci, was Foundation Professor of Clinical Pharmacology in the University of Cambridge, and is now Professor of Endocrine Hypertension at Barts and the London School of Medicine. He was President of the British Hypertension Society 2005-2007 and led the British Heart Foundation-funded PATHWAY programme of trials in hypertension, jointly with investigators in Glasgow, Edinburgh and Dundee. His current research concerns the pathogenesis and management of primary aldosteronism. Recent findings include the introduction of a non-invasive PET-CT scan, and the discovery of mutations causing a commonly missed subtype of small adrenal adenomas. He was awarded the Lilly Gold Medal of the British Pharmacological Society (2002), the Walter Somerville Medal of the British Cardiac Society (2006), the Royal College of Physicians/Lancet award (2016) for outstanding research contributing to excellent patient care, and the Robert Tigerstedt Lifetime Achievement award of the International Society of Hypertension (2018).
|Dr Neil Chapman, Imperial College Healthcare Trust, UK
Neil Chapman is a consultant physician at St Mary’s & Hammersmith Hospitals and honorary senior lecturer at Imperial College, London. He is a fellow of the British and Irish Hypertension Society and lead clinician for the Peart-Rose Clinic, a tertiary referral centre for hypertension and cardiovascular risk factor management.
|Dr Constantina Chrysochou, Salford Royal NHS Foundation Trust, UK
Consultant Nephrologist at Salford Royal NHS Foundation Trust and Honorary Lecturer at the University of Manchester.
Department lead for Young Adult Transition Medicine and Inpatient governance. Clinical commitments include glomerulonephritis, renovascular disease and dialysis. Research interests are in atheromatous renovascular disease, fibromuscular dysplasia (national RADAR lead for FMD) and nephrogenic systemic fibrosis. Tina is the Trust’s Freedom to Speak up Guardian and President Elect for the Royal Society of Medicine Nephrology section.
|Dr Chris Clark, University of Exeter, UK
Senior Partner in the Mid Devon Medical Practice, I have developed and lead research groups examining the organisation and delivery of hypertension care and the detection and management of postural hypotension. I have a long-standing interest in inter-arm blood pressure difference and lead the international INTERPRESS collaboration, examining aetiology and mortality implications of an inter-arm difference.
|Dr John Cox, Fethard on Sea, Ireland
Dr. John Cox, FRCPI, FRCGP is in general practice at Fethard-on-Sea, Co. Wexford. He is a long-standing member of the BIHS and sits on the Blood Pressure Council of the Irish Heart Foundation.
He co-authored the Irish College of General Practitioners publication “Cardiovascular Disease: Prevention in General Practice”
|Dr Indranil Dasgupta, Heartlands Hospital Birmingham, UK
Dr Dasgupta is a consultant nephrologist at Heartlands Hospital and Honorary Reader at University of Birmingham. His doctoral thesis was on management of hypertension in CKD (University of Nottingham, 2000). His current research interests include treatment resistant hypertension, medication non-adherence, fluid volume management in CKD and cognitive impairment in CKD.
|Dr David Kernick, Exeter, UK
General Practitioner with a special interest in Headache.
|Professor Neil Poulter, Imperial College London, UK
Neil Poulter is Professor of Preventive Cardiovascular Medicine at Imperial College London where he is Director of the Imperial Clinical Trials Unit. He is an Honorary Consultant Physician and Epidemiologist at the Hammersmith Hospital, a past president of the BHS and is currently the President of ISH.
|Professor Chakravarthi Rajkumar, Brighton and Sussex Medical School, UK
Professor Chakravarthi Rajkumar was appointed as the Chair of Geriatric and Stroke Medicine, Brighton & Sussex Medical School, University of Sussex. To date he has been actively involved in research in the field of Geriatrics and Stroke medicine. He is the Divisional Lead for Cardiovascular diseases, stroke, diabetes, metabolic and endocrine, renal disorders for the National Institute of Health Research (NIHR) Clinical Research Network, Kent, Surrey and Sussex.
He has a wide range of research interests which includes clinical trials in the very elderly, hypertension, vascular compliance, living wills and hospital acquired infections in the elderly. He has published over 350 abstracts, peer reviewed papers and book chapters on clinical problems in journals including NEJM, The Lancet and JAMA (total 160 publications, 8,617 citations, H Index 39).
Prof C. Rajkumar, holds offices in a number of national and international research organisations. He is currently the Chief Investigator for White Coat Hypertension (WCH) in the Very Elderly Trial (HYVET 2). This is a multi-centre trial which is funded by the Dunhill Medical Trust. He has been awarded a number of research grants from various charitable organisations including the British Heart Foundation, Dunhill Medical Trust, NIHR (Research for Patient Benefits) and PPP Healthcare. Professor C. Rajkumar was recently awarded the fellowship of the British Hypertension Society.
In addition, he has been a peer reviewer for over 15 international journals and grant funding bodies. Some of these include the British Heart Foundation, NIHR, British Geriatric Society (BGS), Medical Research Council, Singapore, together with many others. He has also been an external examiner for undergraduate and postgraduate medicine to the University of Zambia on four occasions. He has been external examiner of the MD and PhD thesis for a number of UK and international Universities.
Prof C. Rajkumar has been on the grant awarding committee of the National Institute of Neurological Disorders and Stroke (NINDS) which is part of the National Institute of Health (NIH), USA. He is also an advisor on grants funded by the NIHR, National Health and Medical Research Council (NHMRC, Singapore) and the Netherlands Organisation for Health Research and Development. He is an Associate Editor for the Journal Age & Ageing (Oxford University Press) and member of Editorial Boards of other international journal.
|Professor Rhian Touyz, University of Glasgow, UK
Professor Touyz is Director of the Institute of Cardiovascular & Medical Sciences and British Heart Foundation (BHF) Chair of Cardiovascular Medicine, Univ of Glasgow. She also directs the BHF Centre of Research Excellence in Vascular Science and Medicine. She is a clinician-scientist focusing on hypertension research, and honorary consultant at the Queen Elizabeth University Hospital.